Overview

A Trial of PTS Via Intratumoral Injection in Patients With Central Air Way NSCLC Severe Obstruction

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This trial was to evaluate the efficacy of intratumoral PTS injection in alleviating airway obstruction and dyspnea by improving the percentage of lumen patency of patients with central air way NSCLC tumor severe obstruction.
Phase:
Phase 3
Details
Lead Sponsor:
PTS International Inc.